Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assaysXilin Li, Nan Mei, Roberta A. Mittelstaedt et al.|Regulatory Toxicology and Pharmacology|2023Cited by 35
Optimizing the detection of N-nitrosamine mutagenicity in the Ames testRobert H. Heflich, Aisar Atrakchi, Michelle E. Bishop et al.|Regulatory Toxicology and Pharmacology|2024Cited by 31
Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurityTimothy W. Robison, Wei Ding, Mugimane G. Manjanatha et al.|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2021Cited by 20